Paper41567906
Prevalence and Patterns of Dyslipidemia Among Patients With Rheumatoid Arthritis: A Retrospective Cohort Study.
Aldhuhoori MM and 3 others. Cureus, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Prevalence and Patterns of Dyslipidemia Among Patients With Rheumatoid Arthritis: A Retrospective Cohort Study. Papers, record 41567906. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41567906
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prevalence and Patterns of Dyslipidemia Among Patients With Rheumatoid Arthritis: A Retrospective Cohort Study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38216289 | When does obesity exert its effect in conferring risk of developing RA: a large study in cohorts of symptomatic persons at risk. | RMD Open | 2024 | https://conductscience.org/library/papers/38216289 | PubMed |
| 2 | 39532347 | Prevalence of comorbidities among patients with rheumatoid arthritis in the UAE: a case-control study. | BMJ Open | 2024 | https://conductscience.org/library/papers/39532347 | PubMed |
| 3 | 26458977 | High serum cholesterol predicts rheumatoid arthritis in women, but not in men: a prospective study. | Arthritis Res Ther | 2015 | https://conductscience.org/library/papers/26458977 | PubMed |
| 4 | 19854708 | Total cholesterol and LDL levels decrease before rheumatoid arthritis. | Ann Rheum Dis | 2010 | https://conductscience.org/library/papers/19854708 | PubMed |
| 5 | 35628831 | Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022. | J Clin Med | 2022 | https://conductscience.org/library/papers/35628831 | PubMed |
| 6 | 33060323 | The Prevalence of Rheumatoid Arthritis: A Systematic Review of Population-based Studies. | J Rheumatol | 2021 | https://conductscience.org/library/papers/33060323 | PubMed |
| 7 | 38326904 | The association between remnant cholesterol and rheumatoid arthritis: insights from a large population study. | Lipids Health Dis | 2024 | https://conductscience.org/library/papers/38326904 | PubMed |
| 8 | 22991486 | Atherogenic index and high-density lipoprotein cholesterol as cardiovascular risk determinants in rheumatoid arthritis: the impact of therapy with biologicals. | Mediators Inflamm | 2012 | https://conductscience.org/library/papers/22991486 | PubMed |
| 9 | 16855148 | Epidemiological aspects of rheumatoid arthritis: the sex ratio. | Ann N Y Acad Sci | 2006 | https://conductscience.org/library/papers/16855148 | PubMed |
| 10 | 34685413 | Ischemic Heart Disease and Rheumatoid Arthritis-Two Conditions, the Same Background. | Life (Basel) | 2021 | https://conductscience.org/library/papers/34685413 | PubMed |
| 11 | 37600807 | Rheumatoid arthritis and hypothyroidism: a bidirectional Mendelian randomization study. | Front Immunol | 2023 | https://conductscience.org/library/papers/37600807 | PubMed |
| 12 | 31511227 | Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017. | Ann Rheum Dis | 2019 | https://conductscience.org/library/papers/31511227 | PubMed |
| 13 | 36836675 | Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy. | Life (Basel) | 2023 | https://conductscience.org/library/papers/36836675 | PubMed |
| 14 | 36357155 | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. | Ann Rheum Dis | 2023 | https://conductscience.org/library/papers/36357155 | PubMed |
| 15 | 34095011 | Immunologic Aspects of Dyslipidemia: a Critical Regulator of Adaptive Immunity and Immune Disorders. | J Lipid Atheroscler | 2021 | https://conductscience.org/library/papers/34095011 | PubMed |
| 16 | 27156434 | Rheumatoid arthritis. | Lancet | 2016 | https://conductscience.org/library/papers/27156434 | PubMed |
| 17 | 21778898 | The relationship between carotid intima-media thickness and the activity of rheumatoid arthritis. | J Clin Rheumatol | 2011 | https://conductscience.org/library/papers/21778898 | PubMed |
| 18 | 39048336 | Exploring Cardiovascular Risk Factors and Atherosclerosis in Rheumatoid Arthritis. | Eur J Intern Med | 2024 | https://conductscience.org/library/papers/39048336 | PubMed |
| 19 | 37325667 | Lipid metabolism and rheumatoid arthritis. | Front Immunol | 2023 | https://conductscience.org/library/papers/37325667 | PubMed |
| 20 | 37954591 | Dyslipidemia in rheumatoid arthritis: the possible mechanisms. | Front Immunol | 2023 | https://conductscience.org/library/papers/37954591 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41567906
GET https://conductscience.org/api/papers/v1/41567906/references?page=2